BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 10358200)

  • 1. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
    Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
    J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria.
    Heumann D
    J Endotoxin Res; 2001; 7(6):439-41. PubMed ID: 11753213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
    Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
    Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14.
    Su GL; Goyert SM; Fan MH; Aminlari A; Gong KQ; Klein RD; Myc A; Alarcon WH; Steinstraesser L; Remick DG; Wang SC
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G640-5. PubMed ID: 12181178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.
    Hailman E; Vasselon T; Kelley M; Busse LA; Hu MC; Lichenstein HS; Detmers PA; Wright SD
    J Immunol; 1996 Jun; 156(11):4384-90. PubMed ID: 8666811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
    Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
    J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moesin: a potential LPS receptor on human monocytes.
    Amar S; Oyaisu K; Li L; Van Dyke T
    J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
    J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14.
    Yu B; Wright SD
    J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C
    Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
    Troelstra A; de Graaf-Miltenburg LA; van Bommel T; Verhoef J; Van Kessel KP; Van Strijp JA
    J Immunol; 1999 Apr; 162(7):4220-5. PubMed ID: 10201950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
    Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
    Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
    Kitchens RL; Thompson PA
    J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
    Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
    J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR; Lamping N; Hoess A
    J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis.
    Wang SC; Klein RD; Wahl WL; Alarcon WH; Garg RJ; Remick DG; Su GL
    J Surg Res; 1998 Apr; 76(1):67-73. PubMed ID: 9695742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
    Blais DR; Vascotto SG; Griffith M; Altosaar I
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
    Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
    J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.
    Wurfel MM; Wright SD
    J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.